Medical Bulletin 20/June/2025 Dr. Bhumika Maikhuri20 Jun 2025 3:00 PM ISTHere are the top medical bulletins for the day:Digital Inhalers May Predict COPD Flare-Ups: Study FindsDigital inhalers may help predict impending...
Clinical Trial Shows Combination Therapy May Benefit Teens with Type 1 Diabetes Dr. Bhumika Maikhuri20 Jun 2025 8:30 AM ISTA clinical trial has found that combining standard insulin therapy with the investigational drug dapagliflozin can improve kidney function, blood...
Windlas Biotech Gets SEC Nod to Manufacture Dapagliflozin-Pioglitazone FDC Parthika Patel17 Jun 2025 6:20 PM ISTNew Delhi: The Subject Expert Committee (SEC) for Endocrinology & Metabolism under the Central Drugs Standard Control Organisation (CDSCO) has...
Zibotentan-Dapagliflozin Combo Shows Promising Results in CKD Patients With and Without Diabetes: Study Medha Baranwal15 Jun 2025 9:15 PM ISTDenmark: A recent post hoc analysis from the ZENITH-CKD trial suggests that combining zibotentan, a selective endothelin receptor antagonist, with...
Dapagliflozin Improves MASH Without worsening liver fibrosis in new Trial Dr. Shravani Dali12 Jun 2025 11:00 AM ISTResearchers have found in a randomized trial in China that dapagliflozin, an SGLT2 inhibitor, improved metabolic dysfunction-associated...
Suspected spurious drugs worth Rs 5.21 lakh seized in Hyderabad Ruchika Sharma6 Jun 2025 5:30 PM ISTTelangana: In a raid conducted at the residence of a habitual offender in Hyderabad, the Drugs Control Administration, Telangana has...
Diabetes drug shows benefits for patients with liver disease: Study Dr. Kamal Kant Kohli5 Jun 2025 5:30 AM ISTThe sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients...
CDSCO Panel Approves BE Study for Alkem's Dapagliflozin, Pioglitazone, Metformin FDC, Seeks Revised Phase III Plan Dr. Divya Colin2 Jun 2025 1:51 PM ISTNew Delhi: Alkem Laboratories has received approval from the Subject Expert Committee (SEC) under the Central Drug Standard Control Organisation...
Justify Sample Size Hike in FDC Trial of Zibotentan-Dapagliflozin, CDSCO Panel Tells AstraZeneca Dr. Divya Colin31 May 2025 6:04 PM ISTNew Delhi: Reviewing the amendment protocol of the AstraZeneca's fixed dose combination (FDC) Zibotentan plus Dapagliflozin, the Subject Expert...
Ajanta Pharma Launches Met-XL D to Improve Outcomes for Heart Failure and Post-Myocardial Infarction Patients Deeksha Bhandari22 May 2025 12:30 PM ISTAjanta Pharma, one of the leaders in the cardiology segment has launched the fixed dose combination of Metoprolol and Dapagliflozin under the brand...
NPPA fixes ceiling prices for 84 drug formulations; focus on Empagliflozin-based Diabetes therapies Ruchika Sharma8 May 2025 2:14 PM ISTNew Delhi: In a fresh directive aimed at curbing treatment costs and improving access to essential medicines, the National Pharmaceutical Pricing...
4 Diabetes Medication FDCs including Glimipride Metformin Strength banned by Health Ministry Farhat Nasim18 April 2025 6:13 PM ISTDelhi: The Central Drugs Standard Control Organization (CDSCO) has banned the manufacture, sale, and distribution of certain widely used strengths of...
